Skip to main content
WCS
Menu
Library
Library Catalog
eJournals & eBooks
WCS Research
Archives
Research Use
Finding Aids
Digital Collections
WCS History
WCS Research
Research Publications
Science Data
Services for WCS Researchers
Archives Shop
Bronx Zoo
Department of Tropical Research
Browse By Product
About Us
FAQs
Intern or Volunteer
Staff
Donate
Search WCS.org
Search
search
Popular Search Terms
WCS History
Library and Archives
Library and Archives Menu
Library
Archives
WCS Research
Archives Shop
About Us
Donate
en
fr
Title
Morbidity and Mortality in Amur, Sumatran, and Malayan Tigers (Panthera tigris altaica, Panthera tigris sumatrae, and Panthera tigris jacksoni) Between 2015–2021
Author(s)
Ryker L. Minch; Denise McAloose; Tara M. Harrison
Published
2022
Abstract
Tigers (Panthera tigris) were prevalent throughout Asia in the early 20th century, numbering as many as 100,000 individuals. As of 2014, tigers are listed as endangered and there may be fewer than 3,200 living adults in the wild. It is important to establish a healthy population of tigers in human care to safeguard the species against the uncertain future of today’s wild populations. The Associations of Zoos and Aquariums (AZA) has established Species Survival Programs for three tiger subspecies: Amur (Panthera tigris altaica), Sumatran (Panthera tigris sumatrae), and Malayan (Panthera tigris jacksoni). To date, there has not been a comprehensive analysis of the morbidity and mortality factors faced by these tiger subspecies in human care. This retrospective study reviewed tiger medical records from multiple institutions from 2015–2021 to evaluate causes of morbidity and mortality. Preliminary data from 44 reviewed tiger medical records indicated that the most common causes of morbidity were integumentary disease (45%), gastrointestinal disease (36%), musculoskeletal injury (25%), and oral/periodontal disease (20%). Thirteen tigers were deceased at the time of study; the most common causes of morbidity in the deceased tigers included renal disease (31%), neoplasia (15%), and musculoskeletal disease (15%). Continued evaluation of disease processes affecting tigers in human care is needed to guide future management and conservation of the species.
Keywords
tigers; morbidity; mortality
Access Full Text
Back
DMX4583600000